These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3193109)
1. Method for determining settling rates of Bacillus thuringiensis serotype H-14 formulations. Mullen GR; Hinkle NC J Am Mosq Control Assoc; 1988 Jun; 4(2):132-7. PubMed ID: 3193109 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Czechoslovak and Soviet Bacillus thuringiensis (serotype H-14) formulations against mosquito larvae. Rettich F J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):53-63. PubMed ID: 2883232 [TBL] [Abstract][Full Text] [Related]
3. Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species. Nayar JK; Knight JW; Ali A; Carlson DB; O'Bryan PD J Am Mosq Control Assoc; 1999 Mar; 15(1):32-42. PubMed ID: 10342266 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of granular corncob formulations of Bacillus thuringiensis serovar israelensis against mosquito larvae using a semi-field bioassay method. Ali A; Xue RD; Lobinske R; Carandang N J Am Mosq Control Assoc; 1994 Dec; 10(4):492-5. PubMed ID: 7707052 [TBL] [Abstract][Full Text] [Related]
5. Comparative bioassays of Bacillus thuringiensis H-14 formulations against four species of mosquitoes in Malaysia. Foo AE; Yap HH Southeast Asian J Trop Med Public Health; 1982 Jun; 13(2):206-10. PubMed ID: 6128794 [TBL] [Abstract][Full Text] [Related]
6. Indoor thermal fogging against vector mosquitoes with two Bacillus thuringiensis israelensis formulations, Vectobac ABG 6511 water-dispersible granules and Vectobac 12AS liquid. Yap HH; Lee YW; Zairi J J Am Mosq Control Assoc; 2002 Mar; 18(1):52-6. PubMed ID: 11998931 [TBL] [Abstract][Full Text] [Related]
7. Comparative toxicity of selected larvicidal formulations against Anopheles stephensi Liston and Aedes aegypti Linn. Mittal PK; Adak T; Batra CP J Commun Dis; 2001 Jun; 33(2):116-20. PubMed ID: 12170930 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of two formulations of Bacillus thuringiensis var. israelensis (H-14) against Aedes vexans and safety to non-target macroinvertebrates. Gharib AH; Hilsenhoff WL J Am Mosq Control Assoc; 1988 Sep; 4(3):252-5. PubMed ID: 3199115 [TBL] [Abstract][Full Text] [Related]
9. Laboratory evaluation of Bacillus thuringiensis H-14 against Aedes aegypti larvae in the northeast region of Thailand. Pipitgool V; Maleewong W; Daenseegaew W; Thaiklar K Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):426-8. PubMed ID: 1818396 [TBL] [Abstract][Full Text] [Related]
10. Performance of ULV formulations (Pesguard 102/Vectobac 12AS) against three mosquito species. Yap HH; Chong AS; Adanan CR; Chong NL; Rohaizat B; Malik YA; Lim SY J Am Mosq Control Assoc; 1997 Dec; 13(4):384-8. PubMed ID: 9474567 [TBL] [Abstract][Full Text] [Related]
11. Laboratory and field efficacy of Bacillus thuringiensis var. Israelensis and Bacillus sphaericus against Anopheles gambiae s.l. and Culex quinquefasciatus in Ouagadougou, Burkina Faso. Majori G; Ali A; Sabatinelli G J Am Mosq Control Assoc; 1987 Mar; 3(1):20-5. PubMed ID: 3504891 [TBL] [Abstract][Full Text] [Related]
12. Integrated management of waste tire mosquitoes utilizing Mesocyclops longisetus (Copepoda: Cyclopidae), Bacillus thuringiensis var. israelensis, Bacillus sphaericus, and methoprene. Tietze NS; Hester PG; Shaffer KR; Prescott SJ; Schreiber ET J Am Mosq Control Assoc; 1994 Sep; 10(3):363-73. PubMed ID: 7807078 [TBL] [Abstract][Full Text] [Related]
13. Protocol for the introduction of new Bacillus thuringiensis Israelensis products into the routine mosquito control program in Germany. Becker N; Rettich F J Am Mosq Control Assoc; 1994 Dec; 10(4):527-33. PubMed ID: 7707059 [TBL] [Abstract][Full Text] [Related]
14. Laboratory evaluation of Bacillus thuringiensis var. israelensis serotype H-14 against mosquito larvae with particular reference to Aedes aegypti. Sharma SK; Wattal BL; Mathur KK J Commun Dis; 1982 Jun; 14(2):106-10. PubMed ID: 7153478 [No Abstract] [Full Text] [Related]
15. Efficacy of Bacillus thuringiensis (H-14) for larval Aedes mosquito control in intermountain meadows in Wyoming. Jones CJ; Lloyd JE J Am Mosq Control Assoc; 1985 Mar; 1(1):51-5. PubMed ID: 3880213 [TBL] [Abstract][Full Text] [Related]
16. A new serovar of Bacillus thuringiensis possessing 28a28c flagellar antigenic structure: Bacillus thuringiensis serovar jegathesan, selectively toxic against mosquito larvae. Seleena P; Lee HL; Lecadet MM J Am Mosq Control Assoc; 1995 Dec; 11(4):471-3. PubMed ID: 8825511 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of slow-release formulations of temephos (Abate) and Bacillus thuringiensis var. israelensis for the control of Aedes aegypti in Puerto Rico. Novak RJ; Gubler DJ; Underwood D J Am Mosq Control Assoc; 1985 Dec; 1(4):449-53. PubMed ID: 2466106 [TBL] [Abstract][Full Text] [Related]
18. Residual activity of Bacillus thuringiensis serovars medellin and jegathesan on Culex pipiens and Aedes aegypti larvae. Thiéry I; Fouque F; Gaven B; Lagneau C J Am Mosq Control Assoc; 1999 Sep; 15(3):371-9. PubMed ID: 10480130 [TBL] [Abstract][Full Text] [Related]
19. Effects of sublethal exposure to Bacillus thuringiensis var. israelensis on larval development and adult size in Aedes aegypti. Hare SG; Nasci RS J Am Mosq Control Assoc; 1986 Sep; 2(3):325-8. PubMed ID: 3507506 [TBL] [Abstract][Full Text] [Related]
20. Comparative delta-endotoxins of Bacillus thuringiensis against mosquito vectors (Aedes aegypti and Culex pipiens). Lonc E; Kucińska J; Rydzanicz K Acta Microbiol Pol; 2003; 52(3):293-300. PubMed ID: 14743982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]